Haruki Kobayashi

1.4k total citations
94 papers, 1.0k citations indexed

About

Haruki Kobayashi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Haruki Kobayashi has authored 94 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Oncology, 48 papers in Pulmonary and Respiratory Medicine and 23 papers in Epidemiology. Recurrent topics in Haruki Kobayashi's work include Lung Cancer Treatments and Mutations (34 papers), Lung Cancer Research Studies (32 papers) and Cancer Immunotherapy and Biomarkers (19 papers). Haruki Kobayashi is often cited by papers focused on Lung Cancer Treatments and Mutations (34 papers), Lung Cancer Research Studies (32 papers) and Cancer Immunotherapy and Biomarkers (19 papers). Haruki Kobayashi collaborates with scholars based in Japan, United States and France. Haruki Kobayashi's co-authors include Kazushige Wakuda, Toshiaki Takahashi, Tateaki Naito, Akira Ono, Haruyasu Murakami, Shota Omori, Hirotsugu Kenmotsu, Masahiro Endo, Nobuaki Mamesaya and M Tsuzuki and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Haruki Kobayashi

88 papers receiving 957 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haruki Kobayashi Japan 20 490 430 164 121 112 94 1.0k
Gordon Yung United States 15 568 1.2× 131 0.3× 349 2.1× 150 1.2× 88 0.8× 46 1.4k
Masaharu Shinkai Japan 13 291 0.6× 142 0.3× 338 2.1× 263 2.2× 155 1.4× 58 993
Mohit Girotra United States 19 292 0.6× 211 0.5× 227 1.4× 299 2.5× 52 0.5× 108 1.1k
Tae In Park South Korea 20 271 0.6× 225 0.5× 132 0.8× 43 0.4× 46 0.4× 73 1.4k
Lindsay Schmidt United States 15 604 1.2× 158 0.4× 298 1.8× 176 1.5× 177 1.6× 27 1.5k
Ryohei Watanabe Japan 12 288 0.6× 157 0.4× 52 0.3× 36 0.3× 36 0.3× 44 638
Armin Witt Austria 20 264 0.5× 313 0.7× 496 3.0× 39 0.3× 39 0.3× 32 1.3k
Shin Sasaki Japan 20 175 0.4× 327 0.8× 262 1.6× 145 1.2× 154 1.4× 56 1.5k
Josine van Beek Netherlands 18 123 0.3× 299 0.7× 357 2.2× 309 2.6× 45 0.4× 44 1.1k
Hidenori Nakama Japan 16 365 0.7× 480 1.1× 155 0.9× 147 1.2× 23 0.2× 48 891

Countries citing papers authored by Haruki Kobayashi

Since Specialization
Citations

This map shows the geographic impact of Haruki Kobayashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haruki Kobayashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haruki Kobayashi more than expected).

Fields of papers citing papers by Haruki Kobayashi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haruki Kobayashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haruki Kobayashi. The network helps show where Haruki Kobayashi may publish in the future.

Co-authorship network of co-authors of Haruki Kobayashi

This figure shows the co-authorship network connecting the top 25 collaborators of Haruki Kobayashi. A scholar is included among the top collaborators of Haruki Kobayashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haruki Kobayashi. Haruki Kobayashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nishioka, Naoya, Tateaki Naito, Takashi Sugino, et al.. (2025). Desensitizing Effect of Intra‐Tumoral GDF‐15 on Immunotherapy in Patients With Advanced Non‐Small Cell Lung Cancer. Thoracic Cancer. 16(10). e70089–e70089.
2.
Naito, Tateaki, Keita Miura, Nobuaki Mamesaya, et al.. (2025). Effect of Cancer Cachexia on the Efficacy and Treatment Delivery of Chemotherapy in Older Patients With Advanced Small Cell Lung Cancer. Thoracic Cancer. 16(12). e70104–e70104. 1 indexed citations
3.
Kobayashi, Haruki. (2024). Thoracic lymphangitis as an immune-related adverse event: a case report. BMC Pulmonary Medicine. 24(1). 299–299.
4.
Iida, Yuko, Kazushige Wakuda, Hirotsugu Kenmotsu, et al.. (2024). Efficacy of second-line chemotherapy in patients with pulmonary large cell neuroendocrine carcinoma. Scientific Reports. 14(1). 7641–7641. 1 indexed citations
5.
Nishio, Makoto, Shuji Murakami, Hisato Kawakami, et al.. (2024). Phase II Study of the Liposomal Formulation of Eribulin (E7389-LF) in Combination with Nivolumab: Results from the Small Cell Lung Cancer Cohort. Cancer Research Communications. 4(1). 226–235. 2 indexed citations
6.
Naito, Tateaki, Keita Miura, Yuko Iida, et al.. (2024). Exploring the relationship between anorexia and therapeutic efficacy in advanced lung cancer treatment: a retrospective study. Thoracic Cancer. 15(25). 1831–1841. 2 indexed citations
7.
8.
Murakami, Haruyasu, Keita Miura, Yuko Iida, et al.. (2023). Safety and efficacy of amrubicin with primary prophylactic pegfilgrastim as second‐line chemotherapy in patients with small cell lung cancer. Thoracic Cancer. 14(35). 3475–3482. 1 indexed citations
9.
Fujiwara, Yutaka, Tetsunari Hase, Naozumi Hashimoto, et al.. (2023). Pharmacokinetic and dose‐finding study of osimertinib in patients with impaired renal function and low body weight. Cancer Science. 114(5). 2087–2097. 7 indexed citations
10.
Miyawaki, Taichi, Hirotsugu Kenmotsu, Naoya Nishioka, et al.. (2022). Clinical impact of tumour burden on the efficacy of PD‐1/PD‐L1 inhibitors plus chemotherapy in non‐small‐cell lung cancer. Cancer Medicine. 12(2). 1451–1460. 4 indexed citations
11.
Nishioka, Naoya, Tateaki Naito, Taichi Miyawaki, et al.. (2022). Impact of losing adipose tissue on outcomes from PD‐1/PD‐L1 inhibitor monotherapy in non‐small cell lung cancer. Thoracic Cancer. 13(10). 1496–1504. 12 indexed citations
12.
Omori, Shota, Takanori Kawabata, Naoya Nishioka, et al.. (2022). Incidence and Treatment Outcome of Radiation Pneumonitis in Patients With Limited-stage Small Cell Lung Cancer Treated With Concurrent Accelerated Hyperfractionated Radiation Therapy and Chemotherapy. Advances in Radiation Oncology. 8(2). 101129–101129. 4 indexed citations
13.
Kenmotsu, Hirotsugu, Takanori Kawabata, Akifumi Notsu, et al.. (2021). Impact of angiogenesis inhibitor eligibility on the prognosis of patients with non‐small cell lung cancer harboring EGFR mutation. Cancer Medicine. 10(21). 7503–7513. 4 indexed citations
14.
Omori, Shota, Koji Muramatsu, Takuya Kawata, et al.. (2021). Trophoblast cell-surface antigen 2 expression in lung cancer patients and the effects of anti-cancer treatments. Journal of Cancer Research and Clinical Oncology. 148(9). 2455–2463. 11 indexed citations
15.
Kobayashi, Haruki, Kazushige Wakuda, Tateaki Naito, et al.. (2021). Chemoradiotherapy for limited-stage small-cell lung cancer and interstitial lung abnormalities. Radiation Oncology. 16(1). 52–52. 17 indexed citations
16.
Miyawaki, Taichi, Kazushige Wakuda, Hirotsugu Kenmotsu, et al.. (2020). Proposing synchronous oligometastatic non–small‐cell lung cancer based on progression after first‐line systemic therapy. Cancer Science. 112(1). 359–368. 8 indexed citations
17.
Nishioka, Naoya, Tateaki Naito, Akifumi Notsu, et al.. (2020). Unfavorable impact of decreased muscle quality on the efficacy of immunotherapy for advanced non‐small cell lung cancer. Cancer Medicine. 10(1). 247–256. 30 indexed citations
18.
Nakashima, Kazuhisa, Tateaki Naito, Haruki Kobayashi, et al.. (2019). Platinum Combination Chemotherapy Is Poorly Tolerated in Malnourished Advanced Lung Cancer Patients with Poor Performance Status. Nutrition and Cancer. 71(5). 767–771. 7 indexed citations
19.
Kobayashi, Haruki, Tateaki Naito, Katsuhiro Omae, et al.. (2018). ILD-NSCLC-GAP index scoring and staging system for patients with non-small cell lung cancer and interstitial lung disease. Lung Cancer. 121. 48–53. 13 indexed citations
20.
Kobayashi, Haruki, S. Kawai, Motohiro Tomizawa, et al.. (1996). Dose-finding study on NM441 in chronic respiratory tract infections. 44. 362–378. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gordon Yung Breakdown of academic impact, for papers by Masaharu Shinkai Breakdown of academic impact, for papers by Mohit Girotra Breakdown of academic impact, for papers by Tae In Park Breakdown of academic impact, for papers by Lindsay Schmidt Breakdown of academic impact, for papers by Ryohei Watanabe Breakdown of academic impact, for papers by Armin Witt Breakdown of academic impact, for papers by Shin Sasaki Breakdown of academic impact, for papers by Josine van Beek Breakdown of academic impact, for papers by Hidenori Nakama
Rankless by CCL
2026